Immunohistochemical	O
staining	O
for	O
thyroid	O
transcription	O
factor	O
-	O
1	O
:	O
a	O
helpful	O
aid	O
in	O
discerning	O
primary	O
site	B-Multi-tissue_structure
of	O
tumor	B-Cancer
origin	O
in	O
patients	O
with	O
brain	B-Cancer
metastases	I-Cancer
.	O

Metastatic	B-Cancer
carcinoma	I-Cancer
of	O
unknown	O
primary	O
origin	B-Multi-tissue_structure
is	O
a	O
perplexing	O
but	O
common	O
problem	O
,	O
accounting	O
for	O
up	O
to	O
10	O
%	O
to	O
15	O
%	O
of	O
all	O
solid	B-Cancer
tumors	I-Cancer
at	O
presentation	O
.	O

Many	O
of	O
these	O
metastases	B-Cancer
presumably	O
arise	O
from	O
primary	B-Cancer
lung	I-Cancer
carcinomas	I-Cancer
,	O
but	O
the	O
morphologic	O
features	O
and	O
immunohistochemical	O
profile	O
of	O
lung	B-Cancer
cancer	I-Cancer
is	O
often	O
too	O
nonspecific	O
to	O
permit	O
unequivocal	O
confirmation	O
.	O

Thyroid	O
transcription	O
factor	O
-	O
1	O
(	O
TTF	O
-	O
1	O
)	O
is	O
expressed	O
in	O
lung	B-Cancer
adenocarcinomas	I-Cancer
and	O
thyroid	B-Cancer
carcinomas	I-Cancer
but	O
not	O
in	O
adenocarcinomas	B-Cancer
arising	O
from	O
other	O
sites	B-Multi-tissue_structure
.	O

For	O
patients	O
with	O
adenocarcinomas	B-Cancer
in	O
the	O
lung	B-Organ
,	O
TTF	O
-	O
1	O
staining	O
is	O
now	O
routinely	O
used	O
to	O
distinguish	O
a	O
primary	B-Cancer
lung	I-Cancer
cancer	I-Cancer
from	O
a	O
lung	B-Organ
metastasis	O
.	O

Along	O
these	O
same	O
lines	O
,	O
TTF	O
-	O
1	O
staining	O
might	O
prove	O
useful	O
in	O
localizing	O
the	O
tumor	B-Cancer
origin	O
of	O
adenocarcinomas	B-Cancer
encountered	O
outside	O
of	O
the	O
lung	B-Organ
.	O

The	O
archival	O
surgical	O
pathology	O
files	O
of	O
The	O
Johns	O
Hopkins	O
Hospital	O
were	O
searched	O
for	O
cases	O
of	O
brain	B-Cancer
metastases	I-Cancer
biopsied	O
between	O
1990	O
and	O
2000	O
.	O

Tissue	B-Tissue
blocks	I-Tissue
were	O
obtained	O
and	O
immunoperoxidase	O
staining	O
was	O
performed	O
using	O
the	O
TTF	O
-	O
1	O
antibody	O
.	O

The	O
medical	O
records	O
were	O
reviewed	O
independent	O
of	O
the	O
staining	O
results	O
to	O
determine	O
site	B-Multi-tissue_structure
of	O
tumor	B-Cancer
origin	O
.	O

Seventy	O
-	O
five	O
patients	O
underwent	O
biopsies	O
of	O
carcinomas	B-Cancer
metastatic	O
to	O
the	O
brain	B-Organ
.	O

At	O
the	O
time	O
of	O
brain	B-Organ
biopsy	O
,	O
the	O
primary	O
site	B-Multi-tissue_structure
of	O
tumor	B-Cancer
origin	O
was	O
known	O
in	O
45	O
cases	O
and	O
unknown	O
in	O
30	O
cases	O
.	O

Ultimately	O
,	O
the	O
primary	O
site	B-Multi-tissue_structure
was	O
established	O
on	O
clinical	O
and	O
radiographic	O
grounds	O
in	O
71	O
cases	O
(	O
95	O
%	O
)	O
.	O

These	O
included	O
40	O
(	O
56	O
%	O
)	O
metastases	B-Cancer
from	O
a	O
primary	B-Cancer
lung	I-Cancer
carcinoma	I-Cancer
and	O
31	O
(	O
44	O
%	O
)	O
metastases	B-Cancer
from	O
some	O
nonpulmonary	B-Cancer
carcinoma	I-Cancer
.	O

TTF	O
-	O
1	O
staining	O
was	O
present	O
in	O
31	O
of	O
the	O
40	O
(	O
78	O
%	O
)	O
metastatic	B-Cancer
lung	I-Cancer
carcinomas	I-Cancer
,	O
but	O
in	O
only	O
1	O
of	O
the	O
31	O
(	O
3	O
%	O
)	O
metastatic	B-Cancer
nonpulmonary	I-Cancer
carcinomas	I-Cancer
(	O
a	O
small	B-Cancer
-	I-Cancer
cell	I-Cancer
carcinoma	I-Cancer
of	O
the	O
sinonasal	B-Organism_subdivision
tract	I-Organism_subdivision
)	O
.	O

When	O
the	O
metastatic	B-Cancer
lung	I-Cancer
carcinomas	I-Cancer
were	O
subtyped	O
,	O
TTF	O
-	O
1	O
staining	O
was	O
noted	O
in	O
11	O
of	O
11	O
(	O
100	O
%	O
)	O
adenocarcinomas	B-Cancer
,	O
in	O
6	O
of	O
7	O
(	O
86	O
%	O
)	O
small	B-Cancer
-	I-Cancer
cell	I-Cancer
carcinomas	I-Cancer
,	O
in	O
15	O
of	O
19	O
(	O
79	O
%	O
)	O
large	B-Cancer
-	I-Cancer
cell	I-Cancer
carcinomas	I-Cancer
,	O
and	O
in	O
none	O
of	O
3	O
(	O
0	O
%	O
)	O
squamous	B-Cancer
cell	I-Cancer
carcinomas	I-Cancer
.	O

TTF	O
-	O
1	O
staining	O
is	O
very	O
reliable	O
in	O
discerning	O
whether	O
a	O
brain	B-Organ
metastasis	O
has	O
arisen	O
from	O
a	O
pulmonary	B-Multi-tissue_structure
or	O
nonpulmonary	B-Multi-tissue_structure
site	I-Multi-tissue_structure
,	O
particularly	O
when	O
dealing	O
with	O
adenocarcinomas	B-Cancer
and	O
large	B-Cancer
-	I-Cancer
cell	I-Cancer
carcinomas	I-Cancer
.	O

TTF	O
-	O
1	O
immunohistochemistry	O
could	O
focus	O
the	O
search	O
for	O
the	O
primary	B-Cancer
tumor	I-Cancer
for	O
patients	O
presenting	O
with	O
brain	B-Organ
metastasis	O
as	O
the	O
initial	O
manifestation	O
.	O

